Reply to thread

Message: [QUOTE="ctchamps, post: 3516249, member: 37"] Emory University is conducting a study on remdesivir. It's a double blind study (the largest in the world for this drug) with results to be reported in about a week. The head of the study does not know who received a placebo and who received remdesivir but he stated that a number of patients have a reduction in the duration of infection. It's obvious he believes those patients are getting remdesivir even if he can't state it. If these people have antibodies against the virus then we have a treatment for at least some portion of the population. Brazil just discontinued a study on Hydroxychloroquine/Azithromycin after concluding there is no benefit to patients. Some people in the Emory hospital are refusing to partake in the trial insisting on the antimalarial modality of treatment. I'll wait for the studies conducted by WHO and the CDC to determine if the antimalarial treatment is effective or not. Humanity is desperate for something but these medicines are not absolutely safe. If they are indeed ineffective we could be killing an equal percentage of people with indiscriminate usage of the antimalarial medications as the Coronid-19 virus. In the best of times there are problems with medications and not all of those problems were the result of graft. Under current conditions we can expect hysteria to increase the chances of problems. That certainly doesn't mean that everyone pursuing a treatment is corrupt. There is validity behind the majority of the scientific communities reluctance to give the green light to any of these proposed solutions without at least some study. The compromise is the choice to allow promising studies to fast track without further studies to determine if the treatment is worse than the disease. [/QUOTE]

Verification: First name of men's bb coach